Skip to content

Calliditas to present at upcoming investor conferences

Non Regulatory

Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) (“Calliditas”) today announced that management will present at and participate in the following conferences:

  • The Jefferies London Healthcare Conference, November 14-16 2023, in London, UK. CEO Renee Aguiar-Lucander will present at 2pm GMT on Wednesday 15 November.
  • The Stifel Healthcare Conference 2023, November 15 2023, in New York, USA.
    President of North America, Andrew Udell, will take part in a fireside chat at 10:10am ET on Wednesday 15 November.
  • The SEB Healthcare Seminar, November 21 2023, in Stockholm, Sweden.
  • The Piper Sandler 35th Annual Healthcare Conference, November 28-30 2023 in New York, NY, USA.

CEO Renée Aguiar-Lucander will also be speaking on a panel on Day 2 of the FT Global Pharma & Biotech Summit, which is taking place in November 7 – 9 2023 in London, UK. The Panel ‘Exploring Options for Strategic Partnerships’ will take place at 11:05am GMT on Wednesday 8 November.

For further information, please contact:

Åsa Hillsten, Head of IR & Sustainability, Calliditas

Tel.: +46 76 403 35 43, Email:

The information was sent for publication, through the agency of the contact persons set out above, on November 7, 2023, at 16:00 p.m. CET.